JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.65% |
| 2 | Financials | 10.57% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCWX
2901
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $3.83M | ﹤0.01% |
269,136
-227,633
| -46% | -$2.71M |
|
|
SAGE
2902
CALL
DELISTED
Sage Therapeutics
SAGE
| $3.82M | ﹤0.01% |
44,200
+18,900
| +75% | +$1.39M |
|
2903
Park National Corp
PRK
$3.75B
| $3.82M | ﹤0.01% |
36,409
+17,277
| +90% | +$1.7M |
|
2904
CALL
Okta
OKTA
$25.6B
| $3.81M | ﹤0.01% |
15,000
| – | – |
|
|
CVAC
2905
PUT
DELISTED
CureVac
CVAC
| $3.81M | ﹤0.01% |
+47,000
| New | +$3.6M |
|
2906
Vanguard Russell 1000 Value ETF
VONV
$22B
| $3.81M | ﹤0.01% |
63,600
-296
| -0.5% | -$16.7K |
|
2907
PUT
Bilibili
BILI
$7.3B
| $3.8M | ﹤0.01% |
+44,300
| New | +$2.59M |
|
2908
Seres Therapeutics
MCRB
$45.6M
| $3.79M | ﹤0.01% |
7,735
-1,026
| -12% | -$601K |
|
|
EGIO
2909
DELISTED
Edgio, Inc. Common Stock
EGIO
| $3.79M | ﹤0.01% |
23,714
+4,177
| +21% | +$763K |
|
|
STR
2910
DELISTED
Sitio Royalties
STR
| $3.77M | ﹤0.01% |
299,428
+254,648
| +569% | +$2.58M |
|
2911
PUT
Lowe's Companies
LOW
$122B
| $3.76M | ﹤0.01% |
23,400
-6,500
| -22% | -$1.06M |
|
2912
Addus HomeCare
ADUS
$2.17B
| $3.73M | ﹤0.01% |
31,867
+14,932
| +88% | +$1.54M |
|
2913
Blink Charging
BLNK
$85.9M
| $3.73M | ﹤0.01% |
87,233
+30,170
| +53% | +$596K |
|
2914
CALL
Monster Beverage
MNST
$91.7B
| $3.73M | ﹤0.01% |
+161,200
| New | +$3.39M |
|
2915
Tompkins Financial
TMP
$1.46B
| $3.72M | ﹤0.01% |
52,727
+18,358
| +53% | +$1.16M |
|
2916
Pennant Group
PNTG
$1.37B
| $3.72M | ﹤0.01% |
64,053
+30,888
| +93% | +$1.49M |
|
2917
Ameresco
AMRC
$1.48B
| $3.71M | ﹤0.01% |
71,106
+21,736
| +44% | +$937K |
|
|
KYNB
2918
PUT
Kyntra Bio
KYNB
$28.5M
| $3.71M | ﹤0.01% |
+4,000
| New | +$4.2M |
|
|
BFS
2919
Saul Centers
BFS
$860M
| $3.71M | ﹤0.01% |
116,947
+19,625
| +20% | +$580K |
|
|
ETAC
2920
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
| $3.7M | ﹤0.01% |
+361,992
| New | +$3.56M |
|
2921
Resources Connection
RGP
$145M
| $3.7M | ﹤0.01% |
294,501
+182,703
| +163% | +$2.19M |
|
2922
InMode
INMD
$872M
| $3.7M | ﹤0.01% |
155,760
+83,268
| +115% | +$1.76M |
|
2923
Griffon
GFF
$4.72B
| $3.69M | ﹤0.01% |
181,142
+109,650
| +153% | +$2.36M |
|
|
BMY.RT
2924
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.69M | ﹤0.01% |
5,340,906
-3,553,959
| -40% | -$7.57M |
|
2925
CALL
BP
BP
$110B
| $3.69M | ﹤0.01% |
+179,600
| New | +$3.38M |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.